Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Published on by Nano Technology

Dr. Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Dean, Internal Quality Assurance Cell (IQAC) | Mahayogi Gorakhnath University | India 

Dr. Raghu Ram Achar is an accomplished researcher with a strong publication-driven profile in biochemistry, biomedical sciences, and interdisciplinary life science research. His scholarly output comprises 114 research documents indexed in major databases, reflecting consistent contributions through original research articles, high-quality reviews, book chapters, books, and patents. According to Google Scholar, his work has received 1,342 citations, with an h-index of 19 and an i10-index of 36, demonstrating both sustained productivity and significant academic impact. His research spans enzymology, nanobiotechnology, tissue engineering, cancer biology, mitochondrial research, wound healing, bioinformatics, and computational drug discovery, with publications appearing in high-impact, peer-reviewed international journals. He has actively contributed to funded research projects, interdisciplinary R&D initiatives, innovation-driven studies, and translational research outcomes. His profile is further strengthened by research supervision, peer-review services for reputed journals, editorial and conference roles, and recognized scholarly contributions that collectively position him as a credible and impactful contributor to contemporary biomedical and life sciences research.

Citation Metrics (Google Scholar)

2000

1500

1000

500

0

Citations
1342

Documents
114

h-index
19

i10index
36

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Web Of Science  View Loop Profile  View Scilit Profile  View ScholarGPS

Featured Publications

Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Prof. Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Professor | Shenzhen University of Advanced Technology | China

Prof. Zhifeng You is an emerging researcher in tissue engineering and regenerative biomaterials, with a strong focus on neural repair, nerve injury regeneration, and diabetic wound healing. His work integrates biomaterials, bioinks, and physical cues to advance translational strategies in regenerative medicine. He has published 27 peer-reviewed research articles, including high-impact reviews in leading materials and biomedical journals, contributing significantly to biomaterials-based neural and tissue repair research. His research output has received 1,129 Google Scholar citations, with an h-index of 15 and an i10-index of 18, reflecting consistent scholarly impact, innovation, and recognition within the global biomedical engineering and regenerative medicine research community.

Citation Metrics (Google Scholar)

1200

1000

800

600

400

200

0

Citations
1129

Documents
27

h-index
15

i10index
18

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Researcher Profile

Featured Publications

Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Prof. Dr. Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Laboratory Director | The Affiliated Taian City Central Hospital of Qingdao University | China

Prof. Dr. Zhongtao Zhang is an accomplished researcher in pharmaceutics and translational pharmaceutical sciences, with a strong focus on advanced drug delivery systems, nano-enabled therapeutics, and precision medicine approaches. His research integrates natural medicinal chemistry, pharmaceutical engineering, and tumor-targeted intervention strategies to address critical challenges in disease treatment and drug bioavailability. He has authored 26 scholarly documents indexed in Scopus, achieving 673 citations and an h-index of 14, reflecting the growing impact and recognition of his work. His publications appear in high-impact international journals such as ACS Nano, Chemical Engineering Journal, Materials Today Bio, and Analytical Chemistry, contributing significantly to nanomedicine, biomaterials, and pharmaceutical innovation. Prof. Dr. Zhongtao Zhang has led multiple competitive research projects supported by national and regional funding agencies and holds several national invention patents, demonstrating strong translational and innovation outcomes. His research contributions continue to advance pharmaceutics, interdisciplinary nanotechnology applications, and clinically oriented pharmaceutical R&D.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
673

Documents
26

h-index
14

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fang Wang | Nanomaterials for Medicine | Research Excellence Award

Published on by Nano Technology

Assoc. Prof. Dr. Fang Wang | Nanomaterials for Medicine | Research Excellence Award

China University of Petroleum | China

Assoc. Prof. Dr. Fang Wang is a highly cited researcher with significant contributions to nanotechnology and nanomedicine, reflected by 2,363 Scopus citations across 138 scholarly documents and an h-index of 27. Her research focuses on the design of multifunctional nanoplatforms for precision cancer therapy, integrating DNA nanotechnology, inorganic heterojunctions, and bioresponsive systems. She has made notable advances in targeted drug delivery, photothermal, photodynamic, chemodynamic, and synergistic chemo-therapeutic strategies using programmable nanocomplexes. Her work emphasizes structure–function relationships, catalytic enhancement, and light–matter interactions to achieve high therapeutic efficacy with minimal off-target effects. Assoc. Prof. Dr. Fang Wang’s research outcomes have been published in high-impact international journals, contributing to translational nanomedicine and advanced therapeutic design. She has actively contributed to interdisciplinary R&D, innovation-driven nanomaterial development, peer-review activities, and editorial and conference-related scholarly services, earning recognition for advancing next-generation smart nanotherapeutics.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2363

Documents
138

h-index
27

Citations

Documents

h-index

View Scopus Profile

Featured Publications


Manganese-doped CeO2 nanoparticles with phosphatase-like activity for dual-mode detection of aluminum ions
– Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025 | Citations: 2

Vibha Joshi | Nanotechnology in Medicine and Healthcare | Best Researcher Award

Published on by Nano Technology

Dr. Vibha Joshi | Nanotechnology in Medicine and Healthcare | Best Researcher Award

Teaching Associate | DIT University (Dehradun Institute of Technology) | India

Dr. Vibha Joshi is an emerging researcher with 216 citations, 23 scholarly documents, an h-index of 9, and an i10-index of 9, reflecting strong and growing research impact. Her research focuses on green and sustainable nanotechnology, nanomaterials for biomedical and environmental applications, phytochemistry, catalysis, corrosion inhibition, and targeted drug delivery systems. She has made notable contributions to the green synthesis of metal and metal-oxide nanoparticles, carbon dots, quantum dots, and nanocomposites, integrating in vitro, in vivo, and in silico approaches. Her work addresses critical challenges in antidiabetic, antioxidant, antibacterial, anticancer, and anticorrosion applications, with publications in high-impact Q1 and Q2 international journals. Dr. Vibha Joshi is a patent holder in nanoformulations and functional nanomaterials and has contributed to book chapters on advanced nanostructured materials and herbal nanomedicine. She actively serves as a peer reviewer for reputed journals and contributes to interdisciplinary research advancing sustainable nanoscience, medicinal chemistry, and applied materials research.

Citation Metrics (Google Scholar)

250

200

150

100

50

0

Citations
216

Documents
24

h-index
9

i10index
9

Citations

Documents

h-index

i10-index

View Scopus Profile   View ORCID Profile   View Google Scholar   View ResearchGate

Featured Publications

Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Ms. Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

PhD Student | Centre for Biomaterials and Tissue Engineering (CBIT) – Universitat Politècnica de València (UPV) | Spain

Ms. Sofia Mares Bou is a biomedical engineer with focused research contributions in biomaterials and tissue engineering, emphasizing translational solutions for drug delivery and regenerative medicine. Her scholarly work includes a peer-reviewed journal article in Polymers on core–shell polyvinyl alcohol electrospun microfibers for controlled drug delivery, reflecting expertise in electrospinning, polymeric biomaterials, and therapeutic release systems. She has also presented nationally recognized research on injectable, biomimetic hydrogels for 3D hepatic culture models and hepatotoxicity assessment, contributing to high-throughput in vitro platforms. Ms. Sofia Mares Bou has participated in competitive, publicly funded R&D projects addressing ocular implants for postoperative drug delivery and bioengineered hydrogels with growth-factor presentation. Her research achievements include an award at a national biomedical engineering congress. With Scopus-indexed publications 2, citations 15, and an h-index of 1, her work demonstrates early but impactful contributions to advanced biomaterials, controlled drug delivery, and tissue regeneration research.

Citation Metrics (Scopus)

20

15

10

5

0

Citations
15

Documents
2

h-index
1

Citations

Documents

h-index

View Scopus Profile   View ORCID Profile   View Sci Profiles

Featured Publications

Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Dr. Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Post-Doctorate | Shenzhen University | India

Dr. Shabnam Anjum is a postdoctoral researcher at Shenzhen University with a strong research footprint in biomaterials, nanofibrous scaffolds, extracellular vesicles, and regenerative medicine. Her work focuses extensively on the design, fabrication, and optimization of nanofibers, nanoparticles, microspheres, and hydrogels for tissue regeneration, particularly targeting bone, tendon, and ligament repair. She has contributed significantly to the advancement of electrospinning-based nanofibrous scaffolds, developing bioinspired core–shell systems, multifunctional drug-delivery constructs, and biomimetic matrices capable of modulating osteogenic and osteoclastic activity. Her publications in high-impact journals, including ACS Nano, Materials Today Bio, Frontiers in Bioengineering and Biotechnology, International Journal of Biological Macromolecules, and International Journal of Molecular Sciences, highlight her expertise in biomaterials, stem cell–derived extracellular vesicles, nanostructured drug-delivery systems, and regenerative therapeutics. She has authored influential review articles and innovative research papers demonstrating optimized electrospinning strategies, bioactive scaffold architectures, and decellularized matrix-based regenerative platforms. Her published findings collectively record 250 Scopus citations, 9 documents, and an h-index of 7. Dr. Shabnam Anjum’s emerging research pipeline includes cutting-edge studies on extracellular vesicle engineering, spatiotemporal therapeutic delivery, and osteoporotic bone regeneration. Her technical strengths span electrospinning, nanoparticle synthesis, advanced material characterization, microCT analysis, western blotting, qPCR, flow cytometry, and comprehensive biological evaluations. She has presented her research at prestigious scientific events such as the Chinese Biomaterials Conference and has actively engaged in global scientific webinars covering cancer research, stem cell biology, and precision medicine. She has also contributed to the scientific community through participation in specialized training programs on nanomaterials, animal experimentation, and polymer processing. Her research has been recognized through notable scholarships and academic distinctions, reflecting her dedication to innovative biomaterial development and regenerative therapy. Dr. Shabnam Anjum’s contributions continue to support advancements in nanotechnology-enabled regenerative medicine, positioning her as a promising researcher in the fields of tissue engineering, biomaterials design, and therapeutic nanotechnology.

Profiles: Scopus | Google Scholar | ResearchGate | Sci Profiles | Scilit | Loop

Featured Publications

1. Anjum, S., Rahman, F., Pandey, P., Arya, D. K., Alam, M., Rajinikanth, P. S., & Ao, Q. (2022). Electrospun biomimetic nanofibrous scaffolds: A promising prospect for bone tissue engineering and regenerative medicine. International Journal of Molecular Sciences, 23(16), 9206. https://doi.org/10.3390/ijms23169206

2. Kanaujiya, S., Arya, D. K., Pandey, P., Singh, S., Pandey, G., Anjum, S., … Rajinikanth, P. S. (2024). Resveratrol-ampicillin dual-drug loaded polyvinylpyrrolidone/polyvinyl alcohol biomimic electrospun nanofiber enriched with collagen for efficient burn wound repair. International Journal of Nanomedicine, 19, 5397–5418. https://doi.org/10.2147/IJN.S464046

3. Anjum, S., Wang, Y., Xin, Y., Li, X., Li, T., Zhang, H., Quan, L., Li, Y., Arya, D. K., … Ao, Q. (2024). Bioinspired core-shell nanofiber drug-delivery system modulates osteogenic and osteoclast activity for bone tissue regeneration. Materials Today Bio, 26, 101088. https://doi.org/10.1016/j.mtbio.2024.101088

4. Anjum, S., Li, T., Saeed, M., & Ao, Q. (2024). Exploring polysaccharide and protein-enriched decellularized matrix scaffolds for tendon and ligament repair: A review. International Journal of Biological Macromolecules, 254, 127891. https://doi.org/10.1016/j.ijbiomac.2023.127891

5. Arya, D. K., Deshpande, H., Kumar, A., Chidambaram, K., Pandey, P., Anjum, S., … Pandey, G. (2024). HER-2 receptor and αvβ3 integrin dual-ligand surface-functionalized liposome for metastatic breast cancer therapy. Pharmaceutics, 16(9), 1128. https://doi.org/10.3390/pharmaceutics16091128

Yi Yao | Nanomedicine | Best Researcher Award

Published on by Nano Technology

Prof. Yi Yao | Nanomedicine | Best Researcher Award

Renmin Hospital of Wuhan University | China

Prof. Yi Yao is a distinguished oncologist, Ph.D., Chief Physician, and Director of the Cancer Center at Renmin Hospital of Wuhan University, China, with a career dedicated to advancing cancer treatment and research. He earned his medical degree and doctorate from Wuhan University and received international training as a Visiting Scholar at the German Cancer Research Center, Heidelberg University, and MD Anderson Cancer Center in the United States. His clinical and research interests focus on tumor radiotherapy and the tumor immune microenvironment, with particular emphasis on how irradiation influences tumor biology, radiotherapy efficacy, and radiation-induced lung injury, including the role of fibroblasts and tumor interstitial fibrosis in treatment outcomes. Prof. Yao has secured major research funding from the National Natural Science Foundation of China, the Hubei Natural Science Foundation, and multiple institutional projects, while building collaborations with world-leading cancer research centers in Germany and the United States. He has published extensively in high-impact journals such as Nature Communications, The EMBO Journal, Journal of Clinical Oncology, Cancer Medicine, Histopathology, Nano Letters, and Frontiers in Immunology, in addition to co-editing oncology volumes and holding software copyrights. Recognized with numerous national, provincial, and institutional awards for his contributions to research, clinical practice, and mentorship, Prof. Yao serves on national and provincial oncology committees, is a member of ASCO and ESMO, and continues to mentor doctoral and master’s students, making lasting contributions to oncology education, clinical innovation, and cancer research.

Profile: Orcid

Featured publications

  • Zhang, H., Chen, L., Li, L., Liu, Y., Das, B., Zhai, S., Tan, J., Jiang, Y., Turco, S., Yao, Y., & Frishman, D. (2025). Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning. NPJ Precision Oncology, 9(1), 76.

  • Dong, Y., Khan, L., & Yao, Y. (2024). Immunological features of EGFR-mutant NSCLC and clinical practice. Journal of the National Cancer Center, 4(4), 289–298.

  • Yi, L., Wen, Y., Xiao, M., Yuan, J., Ke, X., Zhang, X., Khan, L., Song, Q., & Yao, Y. (2024). The proportion of tumour stroma predicts response to immune checkpoint inhibitor plus chemotherapy in stage IIIB–IV NSCLC. Histopathology, 85(2), 295–309.

  • Yao, Y., Shen, Y., Yao, J. C., & Zuo, X. (2024). Editorial: New advancement in tumor microenvironment remodeling and cancer therapy. Frontiers in Cell and Developmental Biology, 12, 1384567.

  • Li, Y., Chen, J., Wang, B., Xu, Z., Wu, C., Ma, J., Song, Q., Geng, Q., Yu, J., Pei, H., & Yao, Y. (2023). FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. Drug Resistance Updates, 67, 100926.

  • Yao, Y., Chu, Y., & Xu, B. (2019). Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer. Cancer Medicine, 8(2), 554–563.

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Published on by Nano Technology

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8